NEW TRIAL RECRUITING PV AND ET PATIENTS

  • MPNRF | April 30, 2021

    August 2013

    Incyte Corp. has announced two new trials that are currently recruiting ET and PV patients:

    According to representatives from Incyte, the RELIEF trial is designed to understand better and measure how ruxolitinib treats the burden of symptoms reported by PV patients taking Hydroxyurea. Reported symptoms include tiredness, itching, muscle aches, and night sweats. Dr. Ruben Mesa recently recorded a video discussing PV and these trials in particular. Click here to watch the video.

    For information on either trials, visit clincaltrials.gov. You can also learn more via the Incyte clinical trials hotline: 877-4-PV-Trial (877-478-8742) or http://www.relieftrial.com.